Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
milrinone
Description:
Milrinone is a phosphodiesterase-3 inhibitor used as an inotropic and vasodilator drug to manage heart failure and support cardiac function.
Related topics:
Heart Failure Treatment and Management (18%),
Phosphodiesterase function and regulation (13%)
Wikidata ID:
wiki/Q847399
OpenAlex ID:
keywords/milrinone
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991
·
Milton Packer
, Joseph R. Carver
, et al.
·
New England Journal of Medicine
·
2,232
PDF
Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart Failure A Randomized Controlled Trial
2002
·
Michael S. Cuffe
, Robert M Califf
, et al.
·
JAMA
·
1,195
Clinical features, diagnosis, and management of enterovirus 71
2010
·
Mong How Ooi
, See Chang Wong
, et al.
·
The Lancet Neurology
·
825
PDF
Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease
2003
·
Timothy M. Hoffman
, Gil Wernovsky
, et al.
·
Circulation
·
775
In-Hospital Mortality in Patients With Acute Decompensated Heart Failure Requiring Intravenous Vasoactive Medications
2005
·
William T. Abraham
, Kirkwood F. Adams
, et al.
·
Journal of the American College of Cardiology
·
739
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin
2020
·
Hongde Hu
, Fenglian Ma
, et al.
·
European Heart Journal
·
725
Heart failure etiology and response tomilrinone in decompensated heart failure
2003
·
G.Michael Felker
, Raymond L Benza
, et al.
·
Journal of the American College of Cardiology
·
523
PDF
Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization.
1989
·
W S Colucci
, J P Ribeiro
, et al.
·
Circulation
·
373
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock
2021
·
Rebecca Mathew
, Pietro Di Santo
, et al.
·
New England Journal of Medicine
·
361
PDF
Oocyte Maturation Involves Compartmentalization and Opposing Changes of cAMP Levels in Follicular Somatic and Germ Cells: Studies Using Selective Phosphodiesterase Inhibitors
1996
·
A. Tsafriri
, Sang-Young Chun
, et al.
·
Developmental Biology
·
351
PDF
Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure
1983
·
Donald S. Baim
, Arthur V. McDowell
, et al.
·
New England Journal of Medicine
·
333
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.
1990
·
M Böhm
, P Gierschik
, et al.
·
Circulation
·
326
The Effectiveness and Relative Effectiveness of Intravenous Inotropic Drugs Acting Through the Adrenergic Pathway in Patients with Heart Failure—A Meta-Regression Analysis
2002
·
Simon Thackray
, Joanne Easthaugh
, et al.
·
European Journal of Heart Failure
·
318
PDF
Survival of patients with severe congestive heart failure treated with oral milrinone
1986
·
Donald S. Baim
, Wilson S. Colucci
, et al.
·
Journal of the American College of Cardiology
·
312
PDF
Influence of the Novel Inotropic Agent Levosimendan on Isometric Tension and Calcium Cycling in Failing Human Myocardium
1998
·
Gerd Hasenfuss
, Burkert Pieske
, et al.
·
Circulation
·
302
Milrinone: Systemic and pulmonary hemodynamic effects in neonates after cardiac surgery
1995
·
Anthony C. Chang
, Andrew M. Atz
, et al.
·
Critical Care Medicine
·
280
Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)
2008
·
Liviu Klein
, Barry M. Massie
, et al.
·
Circulation Heart Failure
·
279
Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
1985
·
B E Jaski
, M A Fifer
, et al.
·
Journal of Clinical Investigation
·
261
PDF
Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
1986
·
S A Harrison
, D H Reifsnyder
, et al.
·
Molecular Pharmacology
·
237
Reassessment of Dobutamine, Dopamine, and Milrinone in the Management of Acute Heart Failure Syndromes
2005
·
Melike Bayram
, Leonardo De Luca
, et al.
·
The American Journal of Cardiology
·
233
Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family
2000
·
Yasmin Shakur
, Lena Stenson Holst
, et al.
·
Progress in nucleic acid research and molecular biology
·
218
Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists
2001
·
Luis V. J. Galietta
, Sujatha Jayaraman
, et al.
·
American Journal of Physiology-Cell Physiology
·
214
Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental Animals
1983
·
Adawia A. Alousi
, Jay M. Canter
, et al.
·
Journal of Cardiovascular Pharmacology
·
213
Management strategies for patients with pulmonary hypertension in the intensive care unit*
2007
·
Roham T. Zamanian
, Francois Haddad
, et al.
·
Critical Care Medicine
·
207
Pharmacotherapy Update on the Use of Vasopressors and Inotropes in the Intensive Care Unit
2014
·
Jacob C. Jentzer
, James C. Coons
, et al.
·
Journal of Cardiovascular Pharmacology and Therapeutics
·
206
Show more works
View as search
Works count:
3,981
Citation count:
62,790
Year
Topic
Type